BMY - Bristol-Myers Squibb Co.

Day 1m 10m 60m PreMarket Market AfterHours Gap
46.04 0.16 (0.35%) -0.03 (-0.07%) -0.05 (-0.1%) -0.12 (-0.25%) 0.02 (0.04%) 0.03 (0.07%) 0.02 (0.04%) 0.09 (0.2%)

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.64
Diluted EPS:
0.64
Basic P/E:
72.1927
Diluted P/E:
72.1927
RSI(14) 1m:
56.03
VWAP:
46.21
RVol:

Events

Period Kind Movement Occurred At

Related News